Herbst RS - Search Results

1

Prostate carcinoma response to cytotoxic therapy: in vivo resistance.

Teicher BA, Kakeji Y, Ara G, Herbst RS, Northey D. Teicher BA, et al. Among authors: herbst rs. In Vivo. 1997 Nov-Dec;11(6):453-61. In Vivo. 1997. PMID: 9509295

2

Transforming growth factor-beta 1 overexpression produces drug resistance in vivo: reversal by decorin.

Teicher BA, Ikebe M, Ara G, Keyes SR, Herbst RS. Teicher BA, et al. Among authors: herbst rs. In Vivo. 1997 Nov-Dec;11(6):463-72. In Vivo. 1997. PMID: 9509296

3

Acute in vivo resistance in high-dose therapy.

Teicher BA, Ara G, Keyes SR, Herbst RS, Frei E 3rd. Teicher BA, et al. Among authors: herbst rs. Clin Cancer Res. 1998 Feb;4(2):483-91. Clin Cancer Res. 1998. PMID: 9516940

4

Paclitaxel/carboplatin administration along with antiangiogenic therapy in non-small-cell lung and breast carcinoma models.

Herbst RS, Takeuchi H, Teicher BA. Herbst RS, et al. Cancer Chemother Pharmacol. 1998;41(6):497-504. doi: 10.1007/s002800050773. Cancer Chemother Pharmacol. 1998. PMID: 9554595

5

Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma.

Teicher BA, Williams JI, Takeuchi H, Ara G, Herbst RS, Buxton D. Teicher BA, et al. Among authors: herbst rs. Anticancer Res. 1998 Jul-Aug;18(4A):2567-73. Anticancer Res. 1998. PMID: 9703911

6

Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial.

Herbst RS, Lynch C, Vasconcelles M, Teicher BA, Strauss G, Elias A, Anderson I, Zacarola P, Dang NH, Leong T, Salgia R, Skarin AT. Herbst RS, et al. Cancer Chemother Pharmacol. 2001 Aug;48(2):151-9. doi: 10.1007/s002800100282. Cancer Chemother Pharmacol. 2001. PMID: 11561781 Clinical Trial.

7

Chemotherapy for advanced non-small cell lung cancer.

Herbst RS, Dang NH, Skarin AT. Herbst RS, et al. Hematol Oncol Clin North Am. 1997 Jun;11(3):473-517. doi: 10.1016/s0889-8588(05)70445-7. Hematol Oncol Clin North Am. 1997. PMID: 9209907 Review.

8

Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.

Strauss GM, Lynch TJ, Elias AD, Jacobs C, Herbst R, Leong T, Lynch C, Kwiatkowski DJ, Carey RW, Grossbard ML, Skarin AT. Strauss GM, et al. Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-73-S12-80. Semin Oncol. 1997. PMID: 9331127 Clinical Trial.

9

Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.

Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ. Yano S, et al. Among authors: herbst rs. Clin Cancer Res. 2000 Mar;6(3):957-65. Clin Cancer Res. 2000. PMID: 10741721

10

Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice.

Onn A, Isobe T, Itasaka S, Wu W, O'Reilly MS, Ki Hong W, Fidler IJ, Herbst RS. Onn A, et al. Among authors: herbst rs. Clin Cancer Res. 2003 Nov 15;9(15):5532-9. Clin Cancer Res. 2003. PMID: 14654533

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

426 results

Search Page